NYLIM
DGX icon

New York Life Investment Management’s Quest Diagnostics DGX Stock Holding History

New York Life Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
16,533
+95
+0.6% +$18.6K 0.02% 441
2026
Q1 		$3.22M Buy
16,438
+260
+2% +$50.5K 0.03% 433
2025
Q4 		$2.81M Sell
16,178
-164
-1% -$29.9K 0.02% 451
2025
Q3 		$3.11M Sell
16,342
-391
-2% -$69.4K 0.03% 442
2025
Q2 		$3.01M Buy
16,733
+164
+1% +$28.5K 0.03% 438
2025
Q1 		$2.8M Sell
16,569
-194
-1% -$31.9K 0.03% 462
2024
Q4 		$2.53M Buy
16,763
+219
+1% +$34.1K 0.02% 499
2024
Q3 		$2.57M Sell
16,544
-471
-3% -$70.3K 0.03% 517
2024
Q2 		$2.33M Buy
17,015
+167
+1% +$22.9K 0.02% 519
2024
Q1 		$2.24M Sell
16,848
-777
-4% -$101K 0.02% 535
2023
Q4 		$2.43M Buy
17,625
+25
+0.1% +$3.29K 0.02% 504
2023
Q3 		$2.14M Sell
17,600
-63
-0.4% -$8.39K 0.02% 503
2023
Q2 		$2.48M Buy
17,663
+14
+0.1% +$1.93K 0.03% 457
2023
Q1 		$2.5M Sell
17,649
-441
-2% -$63.1K 0.03% 462
2022
Q4 		$2.83M Sell
18,090
-469
-3% -$67.4K 0.03% 445
2022
Q3 		$2.28M Sell
18,559
-137
-0.7% -$18K 0.03% 477
2022
Q2 		$2.48M Buy
+18,696
New +$2.55M 0.03% 457
2015
Q4 		– Sell
-5,400
Closed -$332K – 98
2015
Q3 		$332K Hold
5,400
– – 0.03% 146
2015
Q2 		$392K Sell
5,400
-200
-4% -$14.8K 0.04% 120
2015
Q1 		$430K Hold
5,600
– – 0.05% 109
2014
Q4 		$376K Hold
5,600
– – 0.05% 129
2014
Q3 		$340K Hold
5,600
– – 0.06% 117
2014
Q2 		$329K Hold
5,600
– – 0.06% 118
2014
Q1 		$324K Buy
5,600
+3,100
+124% +$166K 0.07% 71
2013
Q4 		$134K Hold
2,500
– – 0.03% 121
2013
Q3 		$154K Hold
2,500
– – 0.05% 127
2013
Q2 		$152K Buy
+2,500
New +$149K 0.05% 117

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

New York Life Investment Management's DGX Position: Q2 2026 in Review

New York Life Investment Management increased its Quest Diagnostics (DGX) stake by 0.58% in Q2 2026, buying an estimated $18.6K and bringing the position to 16,533 shares worth $3.5M. The position accounts for 0.02% of the portfolio, ranked #441.

New York Life Investment Management first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • New York Life Investment Management held 16,533 shares of Quest Diagnostics worth $3.5M as of Q2 2026.
  • New York Life Investment Management bought 95 Quest Diagnostics shares in Q2 2026, an estimated $18.6K.
  • Quest Diagnostics made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #441 holding.
  • New York Life Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
  • 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.